Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer. A phase II multicenter study by the Hellenic Cooperative Oncology Group

被引：0
|
作者：
Xiros, Nikolaos [1 ]
Economopoulos, Theofanis [1 ]
Samelis, George [1 ]
Papacostas, Pavlos [1 ]
Efstathiou, Eleni [1 ]
Onyenadum, Adimchi [1 ]
Skarlos, Dimosthenis [1 ]
Bamias, Aristotelis [1 ]
Gogas, Helen [1 ]
Kosmidis, Paris [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Data Off, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group
    Xiros, N
    Papacostas, P
    Economopoulos, T
    Samelis, G
    Efstathiou, E
    Kastritis, E
    Kalofonos, H
    Onyenatum, A
    Skarlos, D
    Bamias, A
    Gogas, H
    Bafaloukos, D
    Samantas, E
    Kosmidis, P
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (05) : 773 - 779
  • [2] Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: A phase II study of the Hellenic Cooperative Oncology Group with biomarker evaluation
    Fountzilas, George
    Bobos, Mattheos
    Kalogera-Fountzila, Anna
    Xiros, Nikolaos
    Murray, Samuel
    Linardou, Helena
    Karayannopoulou, Georgia
    Koutras, Angelos K.
    Bafaloukos, Dimitrios
    Samantas, Epaminondas
    Christodoulou, Christos
    Economopoulos, Theofanis
    Kalogeras, Konstantine T.
    Kosmidis, Paris
    [J]. CANCER INVESTIGATION, 2008, 26 (08) : 784 - 793
  • [3] Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study
    Karavasilis, Vasilios
    Samantas, Epaminontas
    Koliou, Georgia-Angeliki
    Kalogera-Fountzila, Anna
    Pentheroudakis, George
    Varthalitis, Ioannis
    Linardou, Helena
    Rallis, Grigorios
    Skondra, Maria
    Papadopoulos, Georgios
    Papatsibas, George
    Sgouros, Joseph
    Goudopoulou, Athina
    Kalogeras, Konstantine T.
    Dervenis, Christos
    Pectasides, Dimitrios
    Fountzilas, George
    [J]. TARGETED ONCOLOGY, 2018, 13 (06) : 715 - 724
  • [4] Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study
    Vasilios Karavasilis
    Epaminontas Samantas
    Georgia-Angeliki Koliou
    Anna Kalogera-Fountzila
    George Pentheroudakis
    Ioannis Varthalitis
    Helena Linardou
    Grigorios Rallis
    Maria Skondra
    Georgios Papadopoulos
    George Papatsibas
    Joseph Sgouros
    Athina Goudopoulou
    Konstantine T. Kalogeras
    Christos Dervenis
    Dimitrios Pectasides
    George Fountzilas
    [J]. Targeted Oncology, 2018, 13 : 715 - 724
  • [5] Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
    Kosmidis, P. A.
    Kalofonos, H. P.
    Christodoulou, C.
    Syrigos, K.
    Makatsoris, T.
    Skarlos, D.
    Bakogiannis, C.
    Nicolaides, C.
    Bafaloukos, D.
    Bamias, A.
    Samantas, E.
    Xiros, N.
    Boukovinas, I.
    Fountzilas, G.
    Dimopoulos, M. A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (01) : 115 - 122
  • [6] Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study
    Briasoulis, E
    Kalofonos, H
    Bafaloukos, D
    Samantas, E
    Fountzilas, G
    Xiros, N
    Skarlos, D
    Christodoulou, C
    Kosmidis, F
    Pavlidis, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3101 - 3107
  • [7] GEMCITABINE COMBINED WITH THE MTOR INHIBITOR TEMSIROLIMUS(CCI-779) IN PATIENTS WITH INOPERABLE OR METASTATIC PANCREATIC CANCER (HE 3/07). A PHASE I STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
    Karavasilis, V.
    Pentheroudakis, G.
    Sgouros, J.
    Dimoudis, S. T.
    Varthalitis, I.
    Samantas, E.
    Fountzilas, G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 239 - 239
  • [8] Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
    Katopodis, O.
    Souglakos, J.
    Stathopoulos, E.
    Christopoulou, A.
    Kontopodis, E.
    Kotsakis, A.
    Kalbakis, K.
    Kentepozidis, N.
    Polyzos, A.
    Hatzidaki, D.
    Georgoulias, V.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 333 - 340
  • [9] Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
    O. Katopodis
    J. Souglakos
    E. Stathopoulos
    A. Christopoulou
    E. Kontopodis
    A. Kotsakis
    K. Kalbakis
    N. Kentepozidis
    A. Polyzos
    D. Hatzidaki
    V. Georgoulias
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 74 : 333 - 340
  • [10] Gemcitabine (G) combined with gefitinib in patients with inoperable or metastatic pancreatic cancer. A phase II trial
    Fountzilas, G.
    Murray, S.
    Xiros, N.
    Karayannopoulou, G.
    Dafni, U.
    Linardou, H.
    Kalogera-Fountzila, A.
    Bobos, M.
    Koumarianou, A.
    Kosmidis, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345